Shasun Pharmaceuticals estimates a loss of Rs 50 crore from the closure of its Cuddalore plant due to a chemical leak two weeks ago. The plant which makes anti-ulcerant drugs such as Ranitidine, Nizatidine and Gabapentin, expects to start operations in a day or two.
The drug maker reported a profit of Rs 37 lakh on flat revenue of Rs 145 crore for the third quarter ending December 31, 2010. For the preceding quarter ending September 30, 2010, Shasun reported a loss of Rs 5.5 crore on a turnover of Rs 147 crore.crackcrack
